Acurx Pharmaceuticals Inc. (NASDAQ: ACXP)
$0.7197
+0.0207 ( +2.81% ) 155.3K
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Market Data
Open
$0.7197
Previous close
$0.6990
Volume
155.3K
Market cap
$14.03M
Day range
$0.6810 - $0.7350
52 week range
$0.6800 - $4.5300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Nov 13, 2024 |
| 10-q | Quarterly Reports | 51 | Nov 12, 2024 |
| 8-k | 8K-related | 14 | Aug 09, 2024 |
| 10-q | Quarterly Reports | 54 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 8-k | 8K-related | 13 | Jun 17, 2024 |